The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
CNS regulation of appetite
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501 · cited 4×
“The endogenous orexin system consists of two peptides termed OX-A and OX-B along with two G-protein coupled receptors, orexin-1 (OX-1) and orexin-2 (OX-2).”
InfluentialA role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 1×
“This orexigenic effect is mediated, at least in part, by stimulating ARC NPY neurones (see later); administration of antibodies or antagonists to these neuropeptides abolishes ghrelin action (Nakazato et al., 2001; Shintani et al., 2001).”
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 2×
“, 1999) while orexin-knockout mice have disordered wakefulness (Chemelli et al., 1999).”
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 1×
“Huszar and colleagues reported that MC4-R null mice are hyperphagic and exhibit an obese phenotype (Huszar et al., 1997).”
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · cited 2×
“peaking just before meal initiation (Cummings et al., 2001) and”
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494 · cited 2×
“Infusions of ghrelin in lean participants also lead to increases in food intake through concurrent increases in pre-meal hunger and prospective consumption (Wren et al., 2001).”
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Cited by
The role of protein in weight loss and maintenance
Leidy, H. J., Clifton, P. M., Astrup, A., Wycherley, T. P., Westerterp-Plantenga, M. S., Luscombe-Marsh, N. D., Woods, S. C., & Mattes, R. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.084038 · Cited by 475
Sobrino Crespo, C., Perianes Cachero, A., Puebla Jiménez, L., Barrios, V., & Arilla Ferreiro, E. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00058 · Cited by 256
Acosta, A., Camilleri, M., Abu Dayyeh, B., Calderon, G., Gonzalez, D., McRae, A., Rossini, W., Singh, S., Burton, D., & Clark, M. M. (2021) · Obesity · doi:10.1002/oby.23120 · Cited by 222
“We identify within four obesityrelated phenotypes the associated pathophysiological perturbations that underpin, at least in part, the phenotype as summarized here: (a)“hungry brain,” characterized by excessive calories consumed to terminate meal; (b) “emotional hunger,” characterized by negative mood, emotional eatin…”
BackgroundIslam, H., Townsend, L. K., McKie, G. L., Medeiros, P. J., Gurd, B. J., & Hazell, T. J. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00218.2017 · Cited by 100
Pharmacological management of binge eating disorder: current and emerging treatment options
McElroy, S., Guerdjikova, A. I., Mori, N., & O’Melia, A. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s25574 · Cited by 74
“Affected peptides involved in controlling feeding and body weight include neuropeptide Y (eg, by topiramate and zonisamide), amylin (by pramlintide), and glucagon-like peptide-1 (by exenatide and liraglutide).(44,52,59,60) Growing research suggests medications with anorectic or weight loss effects may be helpful for p…”
Metadata
- Authors
- Harrold, J. A., Dovey, T. M., Blundell, J. E., & Halford, J. C. G.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 63
- Issue
- 1
- Pages
- 3-17
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2052926465
- Cited by
- 177
- References
- 34
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CNS regulation of appetite. https://app.cochat.ai/papers/10.1016/j.neuropharm.2012.01.007
- The paper
- Harrold, J. A., Dovey, T. M., Blundell, J. E., & Halford, J. C. G. (2012). CNS regulation of appetite. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2012.01.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.